Bluejay Diagnostics (BJDX) Total Non-Current Liabilities (2020 - 2026)

Bluejay Diagnostics' Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 0.7% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 0.7% YoY), while the FY2025 annual figure was $1.1 million, up 23.94% from the prior year.
• Total Non-Current Liabilities came in at $1.4 million for Q1 2026 at Bluejay Diagnostics, up from $1.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $3.0 million in Q3 2023 to a low of $919357.0 in Q4 2024.
• A 5-year average of $1.7 million and a median of $1.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities soared 60.72% in 2023 and slumped 60.95% in 2024, its largest moves.
• Bluejay Diagnostics' Total Non-Current Liabilities stood at $2.0 million in 2022, then decreased by 0.14% to $2.0 million in 2023, then slumped by 53.13% to $919357.0 in 2024, then gained by 23.94% to $1.1 million in 2025, then grew by 24.09% to $1.4 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.4 million, $1.1 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison